SkinHealth Systems Inc. reported a net loss of $6.6 million for the first quarter of 2026, a significant improvement compared to a net loss of $10.1 million in the same period last year. The company's total revenue for the quarter was $64.9 million, down 6.7% from $69.6 million in Q1 2025. This decline was attributed to decreased sales in both Delivery Systems and Consumables, which fell by 8.3% and 6.1%, respectively. The company noted that unfavorable macroeconomic conditions and a transition to a distributor model in China impacted sales performance.

Operating expenses for the quarter decreased to $46.2 million from $60.6 million in the prior year, primarily due to a reduction in general and administrative expenses, which dropped by 34.6% to $21.9 million. This reduction was driven by lower personnel-related costs, including severance and share-based compensation, as well as decreased legal fees. Selling and marketing expenses also fell by 10.9%, reflecting a strategic focus on cost management. The gross profit margin slightly decreased to 68.5% from 69.8%, primarily due to higher amortization expenses.

In terms of operational metrics, the company reported a decrease in cash, cash equivalents, and restricted cash, which totaled $204.4 million at the end of March 2026, down from $232.7 million at the end of 2025. The company’s total liabilities decreased to $418.0 million from $438.7 million, reflecting a reduction in current liabilities. The headcount remained stable, with no significant changes reported in employee numbers.

Looking ahead, SkinHealth Systems remains focused on expanding its product offerings and enhancing its market presence. The company is actively investing in research and development to drive innovation and improve its product pipeline. However, management acknowledged ongoing macroeconomic challenges, including inflation and potential recessionary pressures, which could impact future performance. The company is committed to monitoring these conditions closely and adapting its strategies as necessary to maintain operational resilience and support long-term growth.

About Beauty Health Co

The Beauty Health Company designs, manufactures, and markets esthetic medical devices and consumables focused on skin and scalp health. Its flagship Hydrafacial brand offers patented hydradermabrasion treatments via proprietary Delivery Systems and consumables, supported by complementary brands SkinStylus (microneedling) and Keravive (scalp care). Serving professional medical providers and estheticians globally, the company employs a razor-and-blades business model, leveraging a community-driven platform to deliver personalized, non-invasive beauty health experiences.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.